치아 재생 시장 규모, 점유율, 동향 분석 보고서 : 종류별, 연령층별, 최종사용자별, 지역별, 부문별 예측(2026-2033년)

Dental Regeneration Market Summary

The global dental regeneration market size was estimated at USD 5.82 billion in 2025 and is projected to reach USD 9.59 billion by 2033, growing at a CAGR of 6.51% from 2026 to 2033. The market growth is primarily driven by the rising prevalence of periodontal diseases and tooth loss, as well as the increasing demand for dental implants.

The growing preference for minimally invasive, tissue-preserving treatments further supports the adoption of regenerative biomaterials and biologics. In addition, advancements in bone graft substitutes, membranes, and growth factor-based therapies are enhancing clinical outcomes and expanding treatment applications.

The rising prevalence of periodontal disease, dental caries, and tooth loss significantly drives the dental regenerative market by increasing the need for tissue restoration procedures. Advanced gum disease often leads to destruction of alveolar bone and soft tissue, creating demand for bone grafts, membranes, and biologic regeneration products. As more patients seek to preserve natural teeth and support dental implants, regenerative therapies become essential. This growing disease burden directly expands the patient pool requiring advanced regenerative solutions.

The shift toward biological and minimally invasive dentistry drives the dental regenerative industry by increasing demand for therapies that preserve and restore natural tissues rather than replace them. Clinicians are adopting bioactive materials, growth factors, and regenerative techniques that promote natural healing with less surgical trauma. This treatment philosophy aligns with patient preferences for conservative, long-term solutions, thereby accelerating the adoption of regenerative products and technologies.

Global Dental Regeneration Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global dental regeneration market report based on type, age group, end user, and region:

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Hard Tissue
  • Dentin
  • Cementum
  • Enamel
• Soft Tissue
  • Gum
  • Pulp
• Age Group Outlook (Revenue, USD Million, 2021 - 2033)
• Pediatric
• Adult
• Geriatric
• End User Outlook (Revenue, USD Million; 2021 - 2033)
• Hospitals
• Dental Clinics
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Type
  • 1.1.2. Age Group
  • 1.1.3. End User
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Dental Regeneration Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Rising prevalence of periodontal & dental diseases
    • 3.2.1.2. Increasing dental implant procedures
    • 3.2.1.3. Shift toward biological & minimally invasive dentistry
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. High cost of regenerative procedures
    • 3.2.2.2. Regulatory hurdles
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Stem cell-based dental therapies
    • 3.2.3.2. Advancements in biomaterials & tissue engineering
    • 3.2.3.3. Tissue engineering & scaffold innovation
    • 3.2.3.4. Regenerative endodontics
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Limited reimbursement frameworks
    • 3.2.4.2. Competition from established alternatives
• 3.3. Dental Regeneration Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Dental Regeneration Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Dental Regeneration Market: Type Movement Analysis, 2025 & 2033 (USD Million)
• 4.3. Global Dental Regeneration Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.3.1. Hard Tissue
    • 4.3.1.1. Hard Tissue dental regeneration market 2021 - 2033 (USD Million)
    • 4.3.1.2. Dentin
      • 4.3.1.2.1. Dentin dental regeneration market 2021 - 2033 (USD Million)
    • 4.3.1.3. Cementum
      • 4.3.1.3.1. Cementum dental regeneration market 2021 - 2033 (USD Million)
    • 4.3.1.4. Enamel
      • 4.3.1.4.1. Enamel dental regeneration market 2021 - 2033 (USD Million)
  • 4.3.2. Soft Tissue
    • 4.3.2.1. Soft tissue dental regeneration market 2021 - 2033 (USD Million)
    • 4.3.2.2. Gum
      • 4.3.2.2.1. Gum dental regeneration market 2021 - 2033 (USD Million)
    • 4.3.2.3. Pulp
      • 4.3.2.3.1. Pulp dental regeneration market 2021 - 2033 (USD Million)

Chapter 5. Dental Regeneration Market: Age Group Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Dental Regeneration Market: Age Group Movement Analysis, 2025 & 2033 (USD Million)
• 5.3. Global Dental Regeneration Market Size & Trend Analysis, by Age Group, 2021 to 2033 (USD Million)
  • 5.3.1. Pediatric
    • 5.3.1.1. Pediatric market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.3.2. Adult
    • 5.3.2.1. Adult market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.3.3. Geriatric
    • 5.3.3.1. Geriatric market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Dental Regeneration Market: End User Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Dental Regeneration Market: End User Movement Analysis, 2025 & 2033 (USD Million)
• 6.3. Global Dental Regeneration Market Size & Trend Analysis, by End User 2021 to 2033 (USD Million)
  • 6.3.1. Hospitals
    • 6.3.1.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. Dental Clinics
    • 6.3.2.1. Dental clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.3.3. Others
    • 6.3.3.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Dental Regeneration Market: Regional Estimates & Trend Analysis by Type, Age Group, and End User

• 7.1. Regional Dashboard
• 7.2. Market Size and Trend Analysis, 2021 to 2033
• 7.3. North America
  • 7.3.1. North America dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Competitive scenario
    • 7.3.2.3. Regulatory framework
    • 7.3.2.4. Reimbursement scenario
    • 7.3.2.5. U.S. dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Competitive scenario
    • 7.3.3.3. Regulatory framework
    • 7.3.3.4. Reimbursement scenario
    • 7.3.3.5. Canada dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Competitive scenario
    • 7.3.4.3. Regulatory framework
    • 7.3.4.4. Reimbursement scenario
    • 7.3.4.5. Mexico dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Competitive scenario
    • 7.4.2.3. Regulatory framework
    • 7.4.2.4. Reimbursement scenario
    • 7.4.2.5. UK dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Competitive scenario
    • 7.4.3.3. Regulatory framework
    • 7.4.3.4. Reimbursement scenario
    • 7.4.3.5. Germany dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Competitive scenario
    • 7.4.4.3. Regulatory framework
    • 7.4.4.4. Reimbursement scenario
    • 7.4.4.5. France dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Competitive scenario
    • 7.4.5.3. Regulatory framework
    • 7.4.5.4. Reimbursement scenario
    • 7.4.5.5. Italy dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Competitive scenario
    • 7.4.6.3. Regulatory framework
    • 7.4.6.4. Reimbursement scenario
    • 7.4.6.5. Spain dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Competitive scenario
    • 7.4.7.3. Regulatory framework
    • 7.4.7.4. Reimbursement scenario
    • 7.4.7.5. Sweden dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Competitive scenario
    • 7.4.8.3. Regulatory framework
    • 7.4.8.4. Reimbursement scenario
    • 7.4.8.5. Denmark dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Competitive scenario
    • 7.4.9.3. Regulatory framework
    • 7.4.9.4. Reimbursement scenario
    • 7.4.9.5. Norway dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. China dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. Japan
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Japan dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. Regulatory framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. India dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Competitive scenario
    • 7.5.5.3. Regulatory framework
    • 7.5.5.4. Reimbursement scenario
    • 7.5.5.5. South Korea dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Competitive scenario
    • 7.5.6.3. Regulatory framework
    • 7.5.6.4. Reimbursement scenario
    • 7.5.6.5. Australia dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Competitive scenario
    • 7.5.7.3. Regulatory framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. Thailand dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Brazil dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Argentina dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.7. Middle East and Africa
  • 7.7.1. Middle East and Africa dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. South Africa dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. Saudi Arabia dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. UAE dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. Kuwait dental regeneration market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis by Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Market Share Analysis, 2025
• 8.4. Company Heat Map Analysis
• 8.5. Strategy Mapping
  • 8.5.1. Expansion
  • 8.5.2. Mergers & Acquisition
  • 8.5.3. Partnerships & Collaborations
  • 8.5.4. New Product Launches
  • 8.5.5. Research And Development
  • 8.5.6. Company Profiles
  • 8.5.7. Dentsply Sirona
    • 8.5.7.1. Company overview
    • 8.5.7.2. Financial Performance
    • 8.5.7.3. Product benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. Bioteck S.p.A.
    • 8.5.8.1. Company overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Product benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. Maxigen Biotech Inc.
    • 8.5.9.1. Company overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Product benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. Institut Straumann AG
    • 8.5.10.1. Company overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Product benchmarking
    • 8.5.10.4. Strategic initiatives
  • 8.5.11. Nobel Biocare Services AG (Envista)
    • 8.5.11.1. Company overview
    • 8.5.11.2. Financial performance
    • 8.5.11.3. Product benchmarking
    • 8.5.11.4. Strategic initiatives
  • 8.5.12. Geistlich Holding
    • 8.5.12.1. Company overview
    • 8.5.12.2. Financial performance
    • 8.5.12.3. Product benchmarking
    • 8.5.12.4. Strategic initiatives
  • 8.5.13. ZimVie Inc.
    • 8.5.13.1. Company overview
    • 8.5.13.2. Financial performance
    • 8.5.13.3. Product benchmarking
    • 8.5.13.4. Strategic initiatives
  • 8.5.14. NovaBone (Halma)
    • 8.5.14.1. Company overview
    • 8.5.14.2. Financial performance
    • 8.5.14.3. Product benchmarking
    • 8.5.14.4. Strategic initiatives
  • 8.5.15. Osteogenics Biomedical (Envista)
    • 8.5.15.1. Company overview
    • 8.5.15.2. Financial performance
    • 8.5.15.3. Product benchmarking
    • 8.5.15.4. Strategic initiatives
  • 8.5.16. Regenity
    • 8.5.16.1. Company overview
    • 8.5.16.2. Financial performance
    • 8.5.16.3. Product benchmarking
    • 8.5.16.4. Strategic initiatives
  • 8.5.17. Medtronic
    • 8.5.17.1. Company overview
    • 8.5.17.2. Financial performance
    • 8.5.17.3. Product benchmarking
    • 8.5.17.4. Strategic initiatives
  • 8.5.18. BioHorizons
    • 8.5.18.1. Company overview
    • 8.5.18.2. Financial performance
    • 8.5.18.3. Product benchmarking
    • 8.5.18.4. Strategic initiatives
  • 8.5.19. REGEDENT AG
    • 8.5.19.1. Company overview
    • 8.5.19.2. Financial performance
    • 8.5.19.3. Product benchmarking
    • 8.5.19.4. Strategic initiatives
  • 8.5.20. IDL Dental Technologies LTD
    • 8.5.20.1. Company overview
    • 8.5.20.2. Financial performance
    • 8.5.20.3. Product benchmarking
    • 8.5.20.4. Strategic initiatives
  • 8.5.21. EUCARE PHARMACEUTICALS (P) LTD
    • 8.5.21.1. Company overview
    • 8.5.21.2. Financial performance
    • 8.5.21.3. Product benchmarking
    • 8.5.21.4. Strategic initiatives
  • 8.5.22. Curasan, Inc.
    • 8.5.22.1. Company overview
    • 8.5.22.2. Financial performance
    • 8.5.22.3. Product benchmarking
    • 8.5.22.4. Strategic initiatives
  • 8.5.23. TBR Dental
    • 8.5.23.1. Company overview
    • 8.5.23.2. Financial performance
    • 8.5.23.3. Product benchmarking
    • 8.5.23.4. Strategic initiatives
  • 8.5.24. DentiumUSA
    • 8.5.24.1. Company overview
    • 8.5.24.2. Financial performance
    • 8.5.24.3. Product benchmarking
    • 8.5.24.4. Strategic initiatives
  • 8.5.25. Tecnoss Dental Srl (Tecnoss s.r.l.)
    • 8.5.25.1. Company overview
    • 8.5.25.2. Financial performance
    • 8.5.25.3. Product benchmarking
    • 8.5.25.4. Strategic initiatives
  • 8.5.26. Unicare Biomedical, Inc.
    • 8.5.26.1. Company overview
    • 8.5.26.2. Financial performance
    • 8.5.26.3. Product benchmarking
    • 8.5.26.4. Strategic initiatives
  • 8.5.27. Neoss
    • 8.5.27.1. Company overview
    • 8.5.27.2. Financial performance
    • 8.5.27.3. Product benchmarking
    • 8.5.27.4. Strategic initiatives
  • 8.5.28. Advanced Medical Solutions Group plc
    • 8.5.28.1. Company overview
    • 8.5.28.2. Financial performance
    • 8.5.28.3. Product benchmarking
    • 8.5.28.4. Strategic initiatives
  • 8.5.29. B&B Dental Implant Company
    • 8.5.29.1. Company overview
    • 8.5.29.2. Financial performance
    • 8.5.29.3. Product benchmarking
    • 8.5.29.4. Strategic initiatives
  • 8.5.30. Botiss
    • 8.5.30.1. Company overview
    • 8.5.30.2. Financial performance
    • 8.5.30.3. Product benchmarking
    • 8.5.30.4. Strategic initiatives
  • 8.5.31. Septodont Holding
    • 8.5.31.1. Company overview
    • 8.5.31.2. Financial performance
    • 8.5.31.3. Product benchmarking
    • 8.5.31.4. Strategic initiatives
  • 8.5.32. Implant Direct Corporation (Envista)
    • 8.5.32.1. Company overview
    • 8.5.32.2. Financial performance
    • 8.5.32.3. Product benchmarking
    • 8.5.32.4. Strategic initiatives
  • 8.5.33. META BIOMED CO,. LTD
    • 8.5.33.1. Company overview
    • 8.5.33.2. Financial performance
    • 8.5.33.3. Product benchmarking
    • 8.5.33.4. Strategic initiatives
  • 8.5.34. SigmaGraft Biomaterials
    • 8.5.34.1. Company overview
    • 8.5.34.2. Financial performance
    • 8.5.34.3. Product benchmarking
    • 8.5.34.4. Strategic initiatives